Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia—a step forward but not the definitive answer
To access this article, please choose from the options below
PII: S0165-0378(09)00451-3
doi:10.1016/j.jri.2009.09.001
© 2009 Published by Elsevier Inc.
